Comparing the effect of thecarotherapy on the range of motion in patients with frozen shoulder

evaluation the effect of tecar therapy in the treatment of frozen shoulder

In this randomized, blinded clinical trial study, 30 patients diagnosed with adhesive capsulitis referred to Baqhai Pour polyclinic will be randomly included in the study. The method of random allocation with block randomization will be used.

At first, the patients with adhesive capsulitis in both groups were evaluated in terms of the studied variables before the start of the intervention and underwent the intervention for 6 weeks. Patients were also evaluated in the third and sixth weeks. The statistical analyzer will not know about the grouping of patients.

Patients with shoulder pain for at least one month and limited passive range of motion in comparison to the contralateral shoulder, diagnosed with adhesive capsulitis by a specialist and willing to participate in the study, are enrolled. Patients with a history of diabetes, hypertension, malignancy, fracture, cyst, or lesion in the shoulder area, contraindications for modalities (phototherapy) in patients with bilateral shoulder involvement, shoulder arthritis, calcific tendinitis, significant trauma history, previous shoulder surgery, infection, rheumatoid arthritis, radiculopathy, or reflex sympathetic dystrophy, and unwillingness to continue treatment are excluded from the study.

The first group was treated for 6 weeks with 3 sessions of thekarotherapy together with oral NSAID treatment and topical ointment, in the second group (control) only received oral NSAID treatment and topical ointment under the supervision of a physical therapist.

Pain intensity and shoulder pain and disability index (SPADI), calculation of range of motion, age and gender and duration of the disease will be recorded by a checklist designed for this purpose.

In this clinical trial study, 30 patients with the diagnosis of adhesive capsulitis, referring to Bekayi Por polyclinic, will be randomly included in the study. Block randomization will be used to randomly assign people in the study groups (intervention group and comparison group). In this method, blocks of 6 (including three people in the intervention group and three people in the comparison group) will be used with a ratio of 1:1. Random Allocation software will be used to generate random sequences. For concealment, the random allocation concealment method will be used in such a way that the random sequences created in this method are recorded on cards and these cards will be placed in sealed envelopes in order. In order to maintain the created sequence, numbering will be done on the outer surface of the envelopes. Finally, the numbered envelopes will be placed in a folder. Then, based on the order of arrival of the eligible participants, the envelopes will be opened and the assigned group of that participant will be known.

In this study, according to the way the treatment process is performed under the supervision of the researcher and is performed for the patients using the Tekar therapy device, the patients and the researcher were aware of the grouping. Of course, at the end of the design, before the data analysis by the analyzer, the names of the groups are changed to groups A and B so that the analyzer does not know about the grouping of patients.

Only a part of the data, such as the information related to the main outcome or the like, can be shared

The access period starts 6 months after the results are published

Researchers working in academic and scientific institutions

The data will be available only to researchers working in academic and scientific institutions

Atefeh Rezaian abarqueiو dr.arezoorezayan@gmail.com

Only the data related to the main results of the study can be presented to the mentioned people after mentioning the valid reason.